Moving preinduction cervical ripening to a lower acuity inpatient setting using the synthetic hygroscopic cervical dilator: a cost-consequence analysis for the United States.
Sita J SaundersJody L GrisamoreTess WongRafael Torrejon TorresRhodri SaundersBrett D EinersonPublished in: Journal of medical economics (2022)
In this theoretical study, implementing a ripening room using SHCDs resulted in the lowest time burden and the second lowest costs. The cheapest option for preinduction cervical ripening was vaginal misoprostol.